Scarica l'app Stockscreener
1.41
2.08%
-0.03
Dopo l'orario di chiusura:
1.42
0.01
+0.71%
Precedente Chiudi:
$1.44
Aprire:
$1.45
Volume 24 ore:
565.57K
Relative Volume:
0.51
Capitalizzazione di mercato:
$190.55M
Reddito:
$200.55M
Utile/perdita netta:
$11.80M
Rapporto P/E:
16.23
EPS:
0.0869
Flusso di cassa netto:
$-26.13M
1 W Prestazione:
-4.08%
1M Prestazione:
+9.30%
6M Prestazione:
-15.06%
1 anno Prestazione:
+42.83%
Intervallo 1D:
$1.41
$1.46
Intervallo di 1 settimana:
$1.41
$1.52
Portata 52W:
$0.85
$2.24
Organigram Global Inc Stock (OGI) Company Profile
Compare OGI vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OGI
Organigram Global Inc
|
1.41 | 190.55M | 200.55M | 11.80M | -26.13M | 0.0869 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.77 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.62 | 48.81B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.03 | 44.67B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.57 | 33.27B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
536.12 | 23.50B | 3.18B | 1.33B | 1.04B | 27.90 |
Organigram Global Inc Stock (OGI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Canaccord Genuity | Buy |
| 2024-07-17 | Ripresa | Canaccord Genuity | Speculative Buy |
| 2024-04-15 | Aggiornamento | Alliance Global Partners | Neutral → Buy |
| 2023-01-13 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-12 | Aggiornamento | Canaccord Genuity | Hold → Speculative Buy |
| 2021-05-11 | Aggiornamento | CIBC | Sector Underperform → Neutral |
| 2021-04-14 | Downgrade | CIBC | Neutral → Sector Underperform |
| 2021-04-08 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2021-03-10 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-13 | Downgrade | Alliance Global Partners | Buy → Neutral |
| 2021-01-13 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| 2020-07-07 | Iniziato | Alliance Global Partners | Buy |
| 2020-01-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-01-13 | Iniziato | BofA/Merrill | Underperform |
| 2020-01-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-10-11 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Organigram Global Inc Borsa (OGI) Ultime notizie
Organigram Extends SHRED Brand Into Fast-Acting Shot-Sized Cannabis Beverages - TipRanks
Promising Cannabis Stocks To Follow NowMarch 11th - MarketBeat
Organigram Sets March 30 Vote on Sanity Group Acquisition and BAT-Funded Expansion - TipRanks
Canada’s Organigram makes $268M move into German cannabis market - Telegraph-Journal
Fast-Acting Cannabis Shots - Trend Hunter
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting - Business Wire
Organigram Global (NASDAQ:OGI) Stock Price Down 2%Should You Sell? - MarketBeat
Organigram Global Sets March 30 Vote on Transformative Acquisition of Germany’s Sanity Group - TipRanks
Analyst Downgrade: How does Organigram Global Inc correlate with Nasdaq2026 Levels & Daily Chart Pattern Signals - baoquankhu1.vn
Dip Buying: Will Organigram Global Inc outperform its industry peersMarket Performance Summary & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Best Cannabis Stocks To Add to Your WatchlistMarch 5th - MarketBeat
Breakouts Watch: Is Organigram Global Incs ROIC above industry averageJuly 2025 Closing Moves & Safe Capital Growth Plans - baoquankhu1.vn
Organigram Global Expands FAST Platform with Launch of SHRED Shotz Cannabis Product - geneonline.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity - The AI Journal
Organigram Global Inc. (OGI) Sees C$4 Target on Improved Outlook - Finviz
Organigram Global Moves to Acquire Germany’s Sanity Group in Financed Deal with BAT Support - TipRanks
Organigram (NASDAQ: OGI) to buy Sanity Group and deepen European reach - Stock Titan
OGI PE Ratio & Valuation, Is OGI Overvalued - Intellectia AI
Organigram Global Inc. (OGI) reports Q1 revenue of $97.3 million, with a consensus of $73.15 million - MSN
Document - SEC.gov
What is Organigram Global Inc.’s valuation compared to sectorWeekly Profit Summary & High Accuracy Investment Signals - mfd.ru
Organigram launches 10 SKUs in Australian medical cannabis market - StratCann
Organigram (OGI) launches Edison and BOXHOT medical vapes, pastilles in Australia - Stock Titan
Organigram Expands Global Footprint With New Medical Cannabis Products in Australia - TipRanks
Organigram (OGI) Expands Product Line in Australia with New Laun - GuruFocus
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia - marketscreener.com
Organigram Launches New Products In Australia (NASDAQ:OGI) - Seeking Alpha
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia – Company AnnouncementFT.com - Financial Times
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Organigram Global Moves to Acquire Stake in Germany’s Sanity Group, Expanding European Cannabis Reach - TipRanks
Organigram to buy Berlin-based Sanity Group in €113.4M upfront deal, expanding cannabis supply network - MSN
Analysts Offer Insights on Healthcare Companies: Organigram Global (OGI) and Spyre Therapeutics (SYRE) - The Globe and Mail
BAT (OGI) tightens Organigram partnership with Sanity deal and equity infusion - Stock Titan
Organigram Global (OGI) inks EUR 130M Sanity Group acquisition deal - Stock Titan
Organigram Secures C$65.2 Million BAT Investment to Back Sanity Group Deal - The Globe and Mail
Analyst loves this Canadian pot stock - Cantech Letter
Analysts Offer Insights on Healthcare Companies: OrganiGram Holdings (OGI) and Qiagen (QGEN) - The Globe and Mail
Organigram Global Inc Strengthens Standards For Consistency TSX Smallcap Index - Kalkine Media
Organigram (OGI) Gains on C$65.2M Investment from British Americ - GuruFocus
Organigram to raise C$65.2 million from BAT for Sanity Group acquisition - Investing.com Nigeria
Alliance Global Partners Reaffirms Their Buy Rating on OrganiGram Holdings (OGI) - The Globe and Mail
BAT boosts Organigram (NASDAQ: OGI) with C$65.2M to fund Sanity buy - Stock Titan
Shareholders Will Be Pleased With The Quality of Organigram Global's (TSE:OGI) Earnings - simplywall.st
BAT Funds $48M for Organigram’s Sanity Group Acquisition - Tobacco Reporter
Cannabis Stocks To Follow TodayFebruary 19th - MarketBeat
Organigram Global Inc. announced that it expects to receive CAD 23.118779 million in funding from BT DE Investments Inc. - marketscreener.com
Canopy, Tilray, Organigram & COMPASS Shift the Landscape - The Dales Report
What's Going On With Organigram Global Stock Thursday? - Benzinga
Small caps to watch: Earnings from MTY Food Group, Organigram’s German acquisition and more - The Globe and Mail
Earnings call transcript: OrganiGram Q1 2026 sees strong revenue growth By Investing.com - Investing.com Nigeria
Organigram Global Inc Azioni (OGI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.15%
3.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):